Cerebral palsy patients at higher risk of receiving opioid prescriptions

Opioids are commonly prescribed as an all-purpose pain killer for patients with the condition

5:00 AM

Author | Valerie Goodwin

prescription pad yellow blue
Jacob Dwyer, Justine Ross, Michigan Medicine

The opioid crisis is an ongoing problem in the United States and certain populations are more susceptible to opioid exposure than others.

One of these populations? Adults with cerebral palsy.

Opioids are one approach to manage pain, but often work better for specific types of issues. Patients with cerebral palsy commonly experience pain, its complex, as it can last for different lengths of time (chronic, short-term) and have unique and many locations of where the pain stems from. For adult patients with cerebral palsy, opioids may not be as helpful to manage these types of pains.

Yet, recent research from the University of Michigan suggests that patients with cerebral palsy are more likely to be exposed to opioids and a higher volume of opioid prescriptions for a longer period of time. These results did not come as a surprise to the researchers.

“There is little research on the mechanisms of pain as individuals with cerebral palsy age throughout their life,” said Daniel Whitney, Ph.D., the lead author of the study and assistant professor of physical medicine and rehabilitation at Michigan Medicine. “Opioids may be prescribed at a higher rate for this population, but if it is not very effective at managing their types of pain, the risk-benefit ratio of opioid therapy seems unfavorably lopsided.”

See also: Opioid prescriptions significantly higher for patients with lifelong disabilities

Not much is known about how opioids impact the overall health of patients with cerebral palsy specifically. While opioids may help to manage short-term pain, they can also introduce side effects, such as mental health and substance abuse disorders, balance issues, and physical health problems.

“Opioids target specific pain mechanisms that can help with some elements of chronic pain, but there is a possibility that different routes for treatment can help target this pain more safely in terms of the person’s overall health,” said Ed Hurvitz, M.D., a physical medicine and rehabilitation specialist at Michigan Medicine and contributor to the paper.

Cerebral palsy populations are already medically vulnerable meaning they may be more likely to experience the negative side effects of opioids. The researchers hope that these findings prompt further research to investigate more appropriate opioid therapy and alternative routes to pain care for patients with cerebral palsy.

Alternatively, other common ways to treat this pain can vary from over-the-counter pain killers to specific stretches and exercises to help the areas of the body impacted. The researchers stress its important for providers to talk with their patients  about which methods are effective for them.

See also: Cerebral Palsy doesn’t cause death in adults, so why is it still listed as an underlying cause?

“The complex pain that patients with cerebral palsy experience can be treated in a variety of ways that have less side effects than opioids and create less exposure to the drug,” said Mark Peterson, Ph.D., M.S., FACSM, associate professor of physical medicine and rehabilitation at Michigan Medicine. “If you are prescribed opioids for pain and don’t feel that it is the right choice for you, it’s important to speak up to your care provider and search for other options.”

Additional authors: Daniel G. Whitney, Mark D. Peterson, and Edward A. Hurvitz

Funding: This work was supported by the National Institutes of Health (R01AR076994) and The American Occupational Therapy Foundation Health Services Research Grant.

Paper cited: “Population- and individual-level trajectories of opioid prescription patterns among adults with cerebral palsy: a retrospective cohort study,” National Public Health Emergency Collection. DOI: 10.1007/s11096-023-01553-5


More Articles About:

All Research Topics Community Health Pharmacy Hospitals & Centers Cerebral Palsy Neurological Disorders
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

lab with microscope vials
Health Lab

The hidden life of parasites like Cyclospora

Michigan Medicine biologists and doctors explain how parasites infect people—and how to respond or reduce your risk
word statin in capital letters blue and pill out of silver case
Health Lab

More than half of U.S. adults now qualify for statins under new guidelines

Cholesterol-lowering medicines called statins can reduce heart attack and stroke risk decades later; a study finds millions more people should be taking them.
close up of cells blue purple pink
Health Lab

Researchers create new path to target hard-to-drug prostate cancer protein

University of Michigan researchers have identified a specific pocket within ERG, a driver of prostate cancer, and have developed a small molecule probe, called PBITE-1, that can bind to it.
U-M hospital
Health Lab

Doctors in the house: History of medical interns and residents at Michigan Medicine

Terms like house officers, interns, residents, PGY, and clinical fellows are all part of academic medicine today. But these ways of describing clinical training stages all grew over times since the late 1800s.
team standing around person using virtual reality headset
Health Lab

How new care models, within a new building launch, are helping optimize patient care

New care models in a new building opening at Michigan Medicine is helping to optimize patient care.
person holding scale with scrubs on and stethoscope
Health Lab

7 things to know about Medicare’s new GLP-1 coverage

Medicare coverage of GLP-1 drugs for weight loss including Wegovy and Zepbound has begun but has limits.